|
|
Volumn 96, Issue 11, 2004, Pages 816-818
|
|
Debate rages over proteomic patterns
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
CA 125 ANTIGEN;
PROSTATE SPECIFIC ANTIGEN;
TUMOR MARKER;
TUMOR PROTEIN;
ARTIFICIAL INTELLIGENCE;
BIOTECHNOLOGY;
BLOOD EXAMINATION;
CANCER DIAGNOSIS;
CANCER RESEARCH;
CLINICAL TRIAL;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC PROCEDURE;
DIFFERENTIAL DIAGNOSIS;
EARLY CANCER;
EARLY DIAGNOSIS;
HUMAN;
MASS SPECTROMETER;
MASS SPECTROMETRY;
NOISE POLLUTION;
NOTE;
OVARY CANCER;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROTEIN ANALYSIS;
PROTEOMICS;
RELIABILITY;
REPRODUCIBILITY;
SENSITIVITY AND SPECIFICITY;
VALIDATION PROCESS;
ANIMAL;
ARTICLE;
ARTIFACT;
CHEMISTRY;
METHODOLOGY;
NEOPLASM;
PEPTIDE MAPPING;
PREDICTION AND FORECASTING;
STANDARD;
ANIMALS;
ARTIFACTS;
CA-125 ANTIGEN;
DIAGNOSIS, DIFFERENTIAL;
HUMANS;
MASS SPECTROMETRY;
NEOPLASM PROTEINS;
NEOPLASMS;
PEPTIDE MAPPING;
PREDICTIVE VALUE OF TESTS;
PROSTATE-SPECIFIC ANTIGEN;
PROTEOMICS;
REPRODUCIBILITY OF RESULTS;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 2942604730
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/96.11.816 Document Type: Note |
|
Times cited : (25)
|
|
References (0)
|